FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893583368> ?p ?o ?g. }

• W2893583368 endingPage "1490" @default.
• W2893583368 startingPage "1475" @default.
• W2893583368 abstract "Trivalent influenza vaccines (TIVs) are currently reimbursed for subjects aged ≥ 65 years and children between 6 and 59 months of age under a national immunization program in South Korea. Quadrivalent influenza vaccines (QIVs) are expected to address the potential problem of influenza B-lineage mismatch for TIVs. The objective of this analysis was to compare the cost effectiveness of QIV versus TIV in children aged 6–59 months and older adults ≥ 65 years of age in South Korea. A 1-year static population model was employed to compare the costs and outcomes of a QIV vaccination program compared with TIV in children aged 6–59 months and older adults ≥ 65 years of age in South Korea. Influenza-related parameters (probabilities, health resource use, and costs) were derived from an analysis of the National Health Insurance System claims database between 2010 and 2013 under a broad and narrow set of International Classification of Diseases, Tenth Revision (ICD-10) codes used to identify influenza. Other inputs were extracted from published literature. Incremental cost-effectiveness ratios (2016 South Korean Won [KRW] per quality-adjusted life-year [QALY] gained) were estimated using a ‘limited’ societal perspective as per the Korean pharmacoeconomic guidelines. QALYs lost due to premature mortality were discounted at 5% annually. For both age groups combined, under the narrow definition of influenza, QIV is expected to prevent nearly 16,000 (2923 in children and 13,011 in older adults) medically attended influenza cases, nearly 8000 (672 in children, 7048 in older adults) cases of complications, and over 230 (0 in children, 238 in older adults) deaths annually compared with TIV. The impact of using QIV versus TIV in this setting translates into savings of KRW 24 billion (KRW 0.6 billion in children, KRW 23.4 billion in older adults) in annual medical costs, and over 2100 (18 in children, 2084 in older adults) QALYs. Under the broad definition, the corresponding results are over 190,000 (50,697 in children, 140,644 in older adults) influenza cases, over 37,000 (12,623 in children, 24,526 in older adults) complications, 270 deaths (0 in children, 270 in older adults), KRW 94.22 billion (KRW 16 billion in children, KRW 78.2 billion in older adults), and over 3500 QALYs saved (316 in children, 3260 in older adults). The use of QIV over TIV was estimated to not be cost effective in children 6–59 months of age, but cost saving in older adults, using the narrow definition of influenza; however, QIV use was cost saving in both age groups using the broad definition. QIV is expected to yield more benefits in older adults ≥ 65 years of age than in children aged 6–59 months due to higher influenza-related mortality and costs among the older adults. Further analyses considering the indirect effects of influenza vaccination in children are required." @default.
• W2893583368 created "2018-10-05" @default.
• W2893583368 creator A5008378982 @default.
• W2893583368 creator A5041266811 @default.
• W2893583368 creator A5044142230 @default.
• W2893583368 creator A5065225107 @default.
• W2893583368 creator A5075150288 @default.
• W2893583368 creator A5081246169 @default.
• W2893583368 creator A5081947809 @default.
• W2893583368 date "2018-09-25" @default.
• W2893583368 modified "2023-10-17" @default.
• W2893583368 title "Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea" @default.
• W2893583368 cites W1024567236 @default.
• W2893583368 cites W1522101321 @default.
• W2893583368 cites W1598417225 @default.
• W2893583368 cites W1824679080 @default.
• W2893583368 cites W1839887488 @default.
• W2893583368 cites W1967014226 @default.
• W2893583368 cites W1985550366 @default.
• W2893583368 cites W1988577838 @default.
• W2893583368 cites W2021625831 @default.
• W2893583368 cites W2029220396 @default.
• W2893583368 cites W2030747356 @default.
• W2893583368 cites W2039737448 @default.
• W2893583368 cites W2050615200 @default.
• W2893583368 cites W2057667954 @default.
• W2893583368 cites W2061732924 @default.
• W2893583368 cites W2071358070 @default.
• W2893583368 cites W2090460210 @default.
• W2893583368 cites W2092809808 @default.
• W2893583368 cites W2095095509 @default.
• W2893583368 cites W2105522418 @default.
• W2893583368 cites W2117419474 @default.
• W2893583368 cites W2118619656 @default.
• W2893583368 cites W2119440126 @default.
• W2893583368 cites W2135292622 @default.
• W2893583368 cites W2136115963 @default.
• W2893583368 cites W2139783431 @default.
• W2893583368 cites W2154631592 @default.
• W2893583368 cites W2159880992 @default.
• W2893583368 cites W2190488447 @default.
• W2893583368 cites W2281149080 @default.
• W2893583368 cites W2472998156 @default.
• W2893583368 cites W2475131042 @default.
• W2893583368 cites W2479575807 @default.
• W2893583368 cites W2508169815 @default.
• W2893583368 cites W2522063477 @default.
• W2893583368 cites W2553620755 @default.
• W2893583368 cites W2560666415 @default.
• W2893583368 cites W2582474750 @default.
• W2893583368 cites W2728463261 @default.
• W2893583368 cites W2765654884 @default.
• W2893583368 cites W2767741206 @default.
• W2893583368 cites W2771069810 @default.
• W2893583368 cites W2781640556 @default.
• W2893583368 cites W2788685606 @default.
• W2893583368 cites W2793073599 @default.
• W2893583368 cites W2799879059 @default.
• W2893583368 cites W2937018725 @default.
• W2893583368 cites W4210978603 @default.
• W2893583368 cites W4211252906 @default.
• W2893583368 cites W4302076775 @default.
• W2893583368 doi "https://doi.org/10.1007/s40273-018-0715-5" @default.
• W2893583368 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6244612" @default.
• W2893583368 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30251078" @default.
• W2893583368 hasPublicationYear "2018" @default.
• W2893583368 type Work @default.
• W2893583368 sameAs 2893583368 @default.
• W2893583368 citedByCount "14" @default.
• W2893583368 countsByYear W28935833682018 @default.
• W2893583368 countsByYear W28935833682019 @default.
• W2893583368 countsByYear W28935833682020 @default.
• W2893583368 countsByYear W28935833682021 @default.
• W2893583368 countsByYear W28935833682022 @default.
• W2893583368 countsByYear W28935833682023 @default.
• W2893583368 crossrefType "journal-article" @default.
• W2893583368 hasAuthorship W2893583368A5008378982 @default.
• W2893583368 hasAuthorship W2893583368A5041266811 @default.
• W2893583368 hasAuthorship W2893583368A5044142230 @default.
• W2893583368 hasAuthorship W2893583368A5065225107 @default.
• W2893583368 hasAuthorship W2893583368A5075150288 @default.
• W2893583368 hasAuthorship W2893583368A5081246169 @default.
• W2893583368 hasAuthorship W2893583368A5081947809 @default.
• W2893583368 hasBestOaLocation W28935833681 @default.
• W2893583368 hasConcept C112930515 @default.
• W2893583368 hasConcept C126322002 @default.
• W2893583368 hasConcept C138816342 @default.
• W2893583368 hasConcept C144024400 @default.
• W2893583368 hasConcept C149923435 @default.
• W2893583368 hasConcept C159110408 @default.
• W2893583368 hasConcept C187212893 @default.
• W2893583368 hasConcept C203014093 @default.
• W2893583368 hasConcept C22070199 @default.
• W2893583368 hasConcept C2779134260 @default.
• W2893583368 hasConcept C2780689484 @default.
• W2893583368 hasConcept C2908647359 @default.
• W2893583368 hasConcept C3008058167 @default.
• W2893583368 hasConcept C3018751465 @default.

• next